Reactivity of Bioremediator Glycerophosphodiesterase
A R T I C L E S
activity. Furthermore, a histidine residue (His81 or His217),
located in the second coordination sphere, was associated with
a catalytically relevant pKa value (∼7.0) and was predicted,
based on crystallographic information, to play a role in
orientating the substrate and/or protonating the leaving group
at low pH.10
The conundrum and challenge of mechanistic studies is the
continuous reconciliation between existing catalytic models and
new experimental data, leading to gradual improvements in the
understanding of the molecular details of a chemical reaction.
Numerous examples illustrate this quest, and the enzyme GpdQ
is a recent and versatile paradigm whose mode of action may
involve an intricate regulatory mechanism. Its efficient use in
bioremediation will be greatly assisted by detailed knowledge
of its mechanism of action, i.e., the various steps of a catalytic
turnover.
Toward this aim, we used stopped-flow fluorescence and
absorbance measurements to monitor structural changes that take
place when substrate is added to the enzyme and correlated these
changes to catalytic properties. Furthermore, we used the
paramagnetic properties of Mn(II) to demonstrate the extent to
which a substrate analogue (phosphate) affects metal ions’
binding affinities to the active site of GpdQ and determined
the dissociation constants of the R and ꢀ metal ion in the absence
or presence of phosphate. In addition, the role of a hydrogen-
bond network that connects the metal ions with the substrate
binding pocket was investigated by (i) site-directed mutagenesis,
whereby His81 and His217 (see above) were replaced by
alanines, and (ii) metal-ion substitution studies. The combined
data demonstrate the mechanistic flexibility of this highly
promiscuous enzyme and may provide the basis for using its
catalytic potential for bioremedial applications. Considering
structural similarities observed in the active sites of GpdQ and
other enzymes of the family of bimetallic metallohydrolases
(e.g., methionine aminopeptidase2,26 or various metallo-ꢀ-
lactamases5), it is possible that the mechanistic scheme described
here applies in a more general sense to other enzymes within
this family. Specifically, it may help to resolve some of the
controversies about the metal-ion content and the role(s) of the
metal ions in catalysis.
Figure 1. Schematic representation of the active site of GpdQ reconstituted
with Co(II).10 The metal ion in the R site (left) is six-coordinate, whereas
the one in the ꢀ site (right) is predominantly five-coordinate. However, a
terminal water ligand (as indicated by the dashed line) is visible in two out
of six subunits in the crystal structure.10 This ligand is within hydrogen-
bonding distance of the amide group of Asn80, the metal-ion-bridging
hydroxide, and the water coordinated to the metal ion in the R site.
ion in the R site is coordinated by four amino acid residues, a
terminal water ligand, and a hydr(oxide) molecule that bridges
the two metal ions. In the ꢀ site, the metal ion may also be
coordinated by four amino acid residues but, based on spec-
troscopic and kinetic data, is predicted to be less tightly bound
(Figure 1).10 In addition, a water molecule coordinated to the ꢀ
metal ion is observed in 2 out of 6 subunits in the crystal
structure (Figure 1). The physiologically relevant metal-ion
composition is unclear; however, the recombinantly expressed,
purified enzyme appears to contain at least one Fe(II) metal
ion (in the R site).12 Metal-ion replacement studies indicate that
GpdQ can operate using a range of divalent transition metal
ions, including Zn(II), Cd(II), and Co(II).10-12,24,25
Through a combination of solid state (X-ray crystallography)
and frozen solution (magnetic circular dichroism (MCD))
studies, possible snapshots of the catalytic mechanism were
obtained that enabled us to propose a reaction mechanism for
the hydrolysis of phosphate esters by GpdQ.10,11,25 It has been
postulated that a catalytically competent binuclear metal center
is assembled only in the presence of substrate or substrate
analogues and that a ligand to the metal ion in the ꢀ site, Asn80
(Figure 1), may play an important role in regulating enzymatic
2. Materials and Methods
Materials. All chemicals were purchased from Sigma-Aldrich,
unless stated otherwise. Bis(para-nitrophenyl) phosphate (bpNPP)
was purchased in the sodium salt form because of its greater
solubility in water. Ethyl para-nitrophenyl phosphate (EtpNPP) was
synthesized by known methods.27 Chemical structures of the
substrates used in this study are shown in Figure S1.
Expression, Purification, and Mutagenesis of GpdQ. GpdQ
(wild-type and mutants) were expressed and purified as described
previously.7 Residues His81 and His217 were replaced by alanine
using the Stratagene QuikChange kit.
Preparation of Metal Ion Derivatives of GpdQ. The Co(II)-
and Cd(II)-derivatives of GpdQ were prepared as previously
described.10,25 The Mn(II) form was prepared by adding a 99.9%
pure metal chloride solution to the apoenzyme (prepared as
described elsewhere10).
Characterization of the Metal Binding Affinity of
Mn(II)-GpdQ. The binding of Mn(II) to apo-GpdQ was monitored
by electron paramagnetic resonance (EPR) at room temperature.
(15) Lindqvist, Y.; Johansson, E.; Kaija, H.; Vihko, P.; Schneider, G. J.
Mol. Biol. 1999, 291, 135–147.
(16) Schenk, G.; Gahan, L. R.; Carrington, L. E.; Mitic´, N.; Valizadeh,
M.; Hamilton, S. E.; de Jersey, J.; Guddat, L. W. Proc. Natl. Acad.
Sci. U.S.A. 2005, 102, 273–278.
(17) Stra¨ter, N.; Beate, J.; Scholte, M.; Krebs, B.; Duff, A. P.; Langley,
D. B.; Han, R.; Averill, B. A.; Freeman, H. C.; Guss, J. M. J. Mol.
Biol. 2005, 351, 233–246.
(18) Schenk, G.; Elliott, T. W.; Leung, E.; Carrington, L. E.; Mitic´, N.;
Gahan, L. R.; Guddat, L. W. BMC Struct. Biol. 2008, 8, 6.
(19) Ho¨pfner, K. P.; Karcher, A.; Craig, L.; Woo, T. T.; Carney, J. P.;
Tainer, J. A. Cell 2001, 105, 473–485.
(20) Hadler, K. S.; Huber, T.; Cassady, A. I.; Weber, J.; Robinson, J.;
Burrows, A.; Kelly, G.; Guddat, L. W.; Hume, D. A.; Schenk, G.;
Flanagan, J. U. BMC Res. Not. 2008, 1, 78.
(21) Shenoy, A. R.; Capuder, M.; Draskovic, P.; Lamba, D.; Visweswariah,
S. S.; Podobnik, M. J. Mol. Biol. 2007, 365, 211–225.
(22) Shenoy, A. R.; Sreenath, N.; Podobnik, M.; Kovacevic, M.; Visweswa-
riah, S. S. Biochemistry 2005, 44, 15695–15704.
(23) Keppetipola, N.; Shuman, S. J. Biol. Chem. 2008, 283, 30942–30949.
(24) Gerlt, J. A.; Whitman, G. J. R. J. Biol. Chem. 1975, 250, 5053–5058.
(25) Mirams, R. E.; Smith, S. J.; Hadler, K. S.; Ollis, D. L.; Schenk, G.;
Gahan, L. R. J. Biol. Inorg. Chem. 2008, 13, 1065–1072.
(26) Lowther, W. T.; Matthews, B. W. Chem. ReV. 2002, 102, 4581–4607.
(27) Hendry, P.; Sargeson, A. M. J. Am. Chem. Soc. 1989, 111, 2521–
2527.
9
J. AM. CHEM. SOC. VOL. 131, NO. 33, 2009 11901